Search results
Results From The WOW.Com Content Network
The National Agency for Food and Drug Administration and Control (NAFDAC) is a Nigerian federal agency under the Federal Ministry of Health that is responsible for regulating and controlling the manufacture, importation, exportation, advertisement, distribution, sale, and use of food, drugs, cosmetics, medical devices, chemicals, and packaged water.
It is the largest and most up-to-date source of information on drug products approved for use in Nigeria by NAFDAC (National Agency for Food & Drug Administration & Control). The use of EMDEX as a reference drug manual is endorsed by the Pharmacists Council of Nigeria, the Nursing & Midwifery Council of Nigeria, and major health institutions.
Nigeria’s drug approval agency has warned people not to buy “miracle” products produced by a church with popular Nigerian Christian televangelist Jeremiah Fufeyin at the helm. Nafdac said ...
By early 2021, NIPRD had discovered Niprimune, a locally made phytomedicine as an adjunct for the management of COVID-19 [14] and was approved by the National Agency for Food and Drug Administration and Control (NAFDAC). [15] The Institute had decried lack of funding to advance its production and further research. [16] [17]
Mojisola Adeyeye. Mojisola Christianah Adeyeye is a Nigerian pharmacist and professor. [1][2] She was appointed the Director-General of National Agency for Food and Drug Administration and Control (NAFDAC) on 3 November 2017 by the President of The Federal Republic of Nigeria, Muhammadu Buhari. [3] Before her appointment as NAFDAC boss, she was ...
COVID-19 portal. v. t. e. COVID-19 vaccination in Nigeria is an ongoing immunization campaign against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), in response to the ongoing pandemic in the country. Vaccination began on 5 March 2021.
t. e. The United States Food and Drug Administration 's Investigational New Drug (IND) program is the means by which a pharmaceutical company obtains permission to start human clinical trials and to ship an experimental drug across state lines (usually to clinical investigators) before a marketing application for the drug has been approved.
Drugs approved under the FDA Accelerated Approval Program still need to be tested in clinical trials using endpoints that demonstrate clinical benefit, and those trials are known as phase 4 confirmatory trials. If the drug later proves unable to demonstrate clinical benefit to patients, the FDA may withdraw approval.